Artificial Intelligence

Katherine Stueland’s honor underscores a major shift in healthcare, as genomic screening and AI promise to end the diagnostic odyssey for rare diseases.

UCLA's Dr. Donald Kohn joins the Jeffrey Modell Foundation to discuss revolutionary gene therapies offering new hope for Primary Immunodeficiency patients.

A new AI-powered solution from Emburse promises to transform expense management by catching errors and fraud before reports are even submitted.

Blink Charging and BetterFleet unite to offer a turnkey solution using AI and digital twins, aiming to de-risk and streamline EV fleet electrification.

At a key summit, Candel Therapeutics will showcase how its oncolytic virus, CAN-3110, uses biomarkers to fight one of the deadliest brain cancers.

Meal-tech leader Tovala is expanding with a 140,340-sq-ft facility, signaling major growth and a new era for specialized industrial real estate.

A new collaboration with Datavant will securely connect real-world health data, aiming to speed up research and deliver life-saving therapies faster.

Rapid7's 2026 awards reveal a shift in cybersecurity, where partners are no longer just resellers but crucial allies in the global, AI-driven fight.

Global tech firm Mastek deepens its UK roots with a new Leeds AI hub, boosting the region's economy and tackling the digital skills gap.

Lantern's expanded cancer solution uses NCI-level expertise and community care to promise better outcomes and a significant return on investment for employers.

Liberty Defense's new hire, a former TSA PreCheck leader, signals a major push into the competitive airport security tech market. What does this mean for travelers?

Financially robust and debt-free, Rail Vision is rapidly expanding its AI safety systems globally while a new quantum computing arm aims to redefine the future of rail.

The online reputation firm Ealixir is moving beyond content removal, launching an editorial service to build AI-proof digital identities through authorship.

BorgWarner secures a key contract for its advanced 800V drive module, signaling a major leap for range-extended EVs and its own market leadership.

New AI-powered tools in Genetec’s Security Center SaaS promise to slash incident investigation time from hours to minutes in complex enterprise environments.

SOFIE Biosciences' FAPI-PRO trial begins, testing a novel radiotracer that could revolutionize the detection of one of the deadliest forms of cancer.

New 3D human tissue models show groundbreaking promise in predicting toxicity for advanced cancer therapies, heralding a major shift away from animal testing.

With a new finance chief and an expanded Austin base, Outdoorsy Group is pivoting its travel tech empire to power the coming age of autonomous mobility.

LiveOne is set to announce three new Fortune 500 partnerships alongside better-than-expected Q3 results, signaling a major push into the enterprise market.

With major conferences ahead, clinical-stage MBX Biosciences aims to impress investors with its promising peptide therapies for endocrine and metabolic disorders.